Maria Creignou

1.8k total citations
12 papers, 23 citations indexed

About

Maria Creignou is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Maria Creignou has authored 12 papers receiving a total of 23 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 4 papers in Genetics and 3 papers in Molecular Biology. Recurrent topics in Maria Creignou's work include Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Maria Creignou is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Maria Creignou collaborates with scholars based in Sweden, United Kingdom and United States. Maria Creignou's co-authors include Stina Söderlund, Fredrik Sandin, Torsten Dahlén, Anna Lübking, Bianca Tesi, Anders Själander, Martin Höglund, Hans Wadenvik, Leif Stenke and Johan Richter and has published in prestigious journals such as Blood, British Journal of Haematology and Bone Marrow Transplantation.

In The Last Decade

Maria Creignou

9 papers receiving 23 citations

Peers

Countries citing papers authored by Maria Creignou

Since Specialization

Citations

This map shows the geographic impact of Maria Creignou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Creignou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Creignou more than expected).

Fields of papers citing papers by Maria Creignou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Creignou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Creignou. The network helps show where Maria Creignou may publish in the future.

Co-authorship network of co-authors of Maria Creignou

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Creignou. A scholar is included among the top collaborators of Maria Creignou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Creignou. Maria Creignou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Title	Journal	Authors	Indexed citations
1	Comorbidities and mutations including single‐ and multihit TET2 mutations in relation to outcome in chronic myelomonocytic leukaemia—A population‐based study	British Journal of Haematology	Maria Creignou, Bianca Tesi et al.	0
2	How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms	HemaSphere	Panagiotis Baliakas, Bianca Tesi et al.	3
3	Competition of dual SF3B1mt clones in MDS-RS is associated with distinct RNA mis-splicing in hematopoietic stem cells	PubMed	Pedro Luís Moura, Yasuhito Nannya et al.	1
4	Tolerability and Clinical Activity of Novel First in Class Oral Agent, Inobrodib (CCS1477), in Combination with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma	Blood	Emma Searle, James Cavet et al.	1
5	P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA	HemaSphere	Emma Searle, Jim Cavet et al.	1
6	[Two cases of VEXAS syndrome].	PubMed	Bianca Tesi, Magnus Tobiasson et al.	2
7	Failure to reach hematopoietic allogenic stem cell transplantation in patients with myelodysplastic syndromes planned for transplantation: a population-based study	Bone Marrow Transplantation	Maria Creignou, Hege Garelius et al.	4
8	Transfusion Patterns during Early Follow-up Predict Overall Survival Independently of IPSS-M in Patients with Myelodysplastic Syndromes	Blood	Maria Creignou, Elsa Bernard et al.	1
9	Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody®-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM)	Blood	Andrew Spencer, Binod Dhakal et al.	3
10	Long-Term Clonal Inversion in an MDS-RS Case with Dual SF3B1 Mutations	Blood	Pedro Luís Moura, Yasuhito Nannya et al.	0
11	Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden	Blood	Maria Creignou, Hannah Bower et al.	0
12	Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register	European Journal Of Haematology	Stina Söderlund, Torsten Dahlén et al.	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact